Investigating co-activator TAZ as a regulator of PAX3-FOXO1, cancer cell stemness, and chemoresistance in fusion-positive rhabdomyosarcoma

Administered By

Awarded By

Contributors

Start/End

  • November 1, 2018 - November 1, 2020